Expanded Access Trial of Belimumab Antibody in RA Patients Who Were Previously Treated Under HGS Protocol LBRA99 (LBRA99)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT00931086
Expanded Access Status : No longer available
First Posted : July 2, 2009
Last Update Posted : October 31, 2012
Information provided by (Responsible Party):
GlaxoSmithKline ( Human Genome Sciences Inc., a GSK Company )

No Study Results Posted on for this Study
  Expanded Access Status : No longer available
  Estimated Primary Completion Date : December 2011
  Estimated Study Completion Date : December 2011